{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:40:05Z","timestamp":1778755205834,"version":"3.51.4"},"reference-count":161,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ad.2016.05.005","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T00:41:37Z","timestamp":1466728897000},"page":"17-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry"],"prefix":"10.1016","volume":"108","author":[{"given":"P.","family":"Nagarajan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Tetzlaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Curry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.G.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2016.05.005_bib0810","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.5858\/133.10.1560","article-title":"Protocol for the examination of specimens from patients with melanoma of the skin","volume":"133","author":"Frishberg","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ad.2016.05.005_bib0815","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2559.2007.02823.x","article-title":"Divergent differentiation in malignant melanomas: a review","volume":"52","author":"Banerjee","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.ad.2016.05.005_bib0820","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2559.2000.00894.x","article-title":"Morphological and immunophenotypic variations in malignant melanoma","volume":"36","author":"Banerjee","year":"2000","journal-title":"Histopathology"},{"issue":"Suppl. 2","key":"10.1016\/j.ad.2016.05.005_bib0825","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1038\/modpathol.3800516","article-title":"Unusual variants of malignant melanoma","volume":"19","author":"Magro","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0830","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-0560.2007.00891.x","article-title":"Immunohistochemical characteristics of melanoma","volume":"35","author":"Ohsie","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0835","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4137\/BMI.S2185","article-title":"Immunohistochemistry as an important tool in biomarkers detection and clinical practice","volume":"5","author":"Matos","year":"2010","journal-title":"Biomark Insights"},{"key":"10.1016\/j.ad.2016.05.005_bib0840","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1081\/CNV-200034896","article-title":"Beyond hematoxylin and eosin \u2013 the role of immunohistochemistry in surgical pathology","volume":"22","author":"Jaffer","year":"2004","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ad.2016.05.005_bib0845","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3181\/00379727-47-13084P","article-title":"Immunological properties of an antibody containing a fluorescent group","volume":"47","author":"Coons","year":"1941","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.ad.2016.05.005_bib0850","first-page":"1143","article-title":"A comparison of melanin bleaching and azure blue counterstaining in the immunohistochemical diagnosis of malignant melanoma","volume":"12","author":"Kligora","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0855","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1440-1827.2011.02667.x","article-title":"Re-evaluation of melanin bleaching using warm diluted hydrogen peroxide for histopathological analysis","volume":"61","author":"Momose","year":"2011","journal-title":"Pathol Int"},{"issue":"Suppl. 2","key":"10.1016\/j.ad.2016.05.005_bib0860","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0560.2008.01130.x","article-title":"Use of immunohistochemistry in melanocytic lesions","volume":"35","author":"Prieto","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0865","doi-asserted-by":"crossref","first-page":"853","DOI":"10.5858\/2009-0717-RAR.1","article-title":"Immunohistochemistry of melanocytic proliferations","volume":"135","author":"Prieto","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ad.2016.05.005_bib0870","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00428-014-1542-5","article-title":"Metastatic melanoma mimicking solitary fibrous tumor: report of two cases","volume":"464","author":"Bekers","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.ad.2016.05.005_bib0875","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/PAI.0b013e3181ee8dcb","article-title":"Immunophenotypic heterogeneity of primary sinonasal melanoma with aberrant expression of neuroendocrine markers and calponin","volume":"19","author":"Lee","year":"2011","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ad.2016.05.005_bib0880","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/modpathol.2015.62","article-title":"Aberrant intermediate filament and synaptophysin expression is a frequent event in malignant melanoma: an immunohistochemical study of 73 cases","volume":"28","author":"Romano","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0885","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.humpath.2013.02.007","article-title":"Value of melanocytic-associated immunohistochemical markers in the diagnosis of malignant melanoma: a review and update","volume":"45","author":"Ordonez","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0890","first-page":"13","article-title":"Diagnostic and prognostic biomarkers in melanoma","volume":"7","author":"Weinstein","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib0895","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/286400a0","article-title":"S100 protein is present in cultured human malignant melanomas","volume":"286","author":"Gaynor","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.ad.2016.05.005_bib0900","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/1097-0142(19820901)50:5<912::AID-CNCR2820500519>3.0.CO;2-U","article-title":"Immunohistochemical demonstration of S100 protein in malignant melanoma and pigmented nevus, and its diagnostic application","volume":"50","author":"Nakajima","year":"1982","journal-title":"Cancer"},{"key":"10.1016\/j.ad.2016.05.005_bib0905","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0046-8177(89)90043-9","article-title":"Typical, dysplastic, congenital, and Spitz nevi: a comparative immunohistochemical study","volume":"20","author":"Palazzo","year":"1989","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0910","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(81)92142-5","article-title":"S100 protein: a marker for human malignant melanomas?","volume":"1","author":"Gaynor","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ad.2016.05.005_bib0915","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrc3893","article-title":"S100 proteins in cancer","volume":"15","author":"Bresnick","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ad.2016.05.005_bib0920","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/CMR.0b013e32831993cc","article-title":"Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse","volume":"19","author":"Egberts","year":"2009","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ad.2016.05.005_bib0925","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/00313029400169021","article-title":"Immunohistochemical analysis of cutaneous malignant melanoma: comparison of S-100 protein, HMB-45 monoclonal antibody and NKI\/C3 monoclonal antibody","volume":"26","author":"Fernando","year":"1994","journal-title":"Pathology"},{"key":"10.1016\/j.ad.2016.05.005_bib0930","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1111\/j.1600-0560.2007.00953.x","article-title":"Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors","volume":"35","author":"Nonaka","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0935","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.humpath.2005.07.010","article-title":"Loss of S100 antigenicity in metastatic melanoma","volume":"36","author":"Aisner","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0940","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaad.2009.11.688","article-title":"P75 nerve growth factor receptor staining is superior to S100 in identifying spindle cell and desmoplastic melanoma","volume":"63","author":"Lazova","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib0945","doi-asserted-by":"crossref","first-page":"20126","DOI":"10.1016\/S0021-9258(17)32136-1","article-title":"Molecular characterization of the melanocyte lineage-specific antigen gp100","volume":"269","author":"Adema","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ad.2016.05.005_bib0950","first-page":"195","article-title":"Monoclonal antibodies specific for melanocytic tumors distinguish subpopulations of melanocytes","volume":"123","author":"Gown","year":"1986","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0955","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1600-0560.1991.tb01233.x","article-title":"Analysis of HMB-45 immunoreactivity in common and cellular blue nevi","volume":"18","author":"Wood","year":"1991","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0960","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00000372-199113060-00004","article-title":"HMB-45 staining in benign and malignant melanocytic lesions. A reflection of cellular activation","volume":"13","author":"Skelton","year":"1991","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0965","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/modpathol.2014.59","article-title":"Comparison of MelanA\/MART-1 and HMB45 labeling in desmoplastic melanoma","volume":"27","author":"Weissinger","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0970","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/dc.21791","article-title":"The use of immunocytochemical study in the cytologic diagnosis of melanoma: evaluation of three antibodies","volume":"41","author":"Jing","year":"2013","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0975","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.1073\/pnas.91.9.3515","article-title":"Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor","volume":"91","author":"Kawakami","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ad.2016.05.005_bib0980","doi-asserted-by":"crossref","first-page":"14006","DOI":"10.1074\/jbc.M413692200","article-title":"MART-1 is required for the function of the melanosomal matrix protein PMEL17\/GP100 and the maturation of melanosomes","volume":"280","author":"Hoashi","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ad.2016.05.005_bib0985","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/00000478-199808000-00007","article-title":"Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma","volume":"22","author":"Busam","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0990","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00125480-199901000-00002","article-title":"Melan-A, a new melanocytic differentiation marker","volume":"6","author":"Busam","year":"1999","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib0995","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00000478-199805000-00011","article-title":"A103: an anti-melan-a monoclonal antibody for the detection of malignant melanoma in paraffin-embedded tissues","volume":"22","author":"Jungbluth","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1000","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00008390-199808000-00007","article-title":"Melan A\/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution","volume":"8","author":"Hofbauer","year":"1998","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ad.2016.05.005_bib1005","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00000372-200410000-00003","article-title":"Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis","volume":"26","author":"El Shabrawi-Caelen","year":"2004","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1010","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/DAD.0b013e31819d3769","article-title":"Melan-a-positive pseudomelanocytic nests: a pitfall in the histopathologic and immunohistochemical diagnosis of pigmented lesions on sun-damaged skin","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1015","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0560.2006.00673.x","article-title":"Immunostaining for MART-1 in the interpretation of problematic intra-epidermal pigmented lesions","volume":"34","author":"Wiltz","year":"2007","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1034\/j.1600-0854.2002.30909.x","article-title":"The melanocytic protein Melan-A\/MART-1 has a subcellular localization distinct from typical melanosomal proteins","volume":"3","author":"De Maziere","year":"2002","journal-title":"Traffic"},{"key":"10.1016\/j.ad.2016.05.005_bib1025","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.6810464","article-title":"Mammalian tyrosinase catalyzes three reactions in the biosynthesis of melanin","volume":"217","author":"Korner","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.ad.2016.05.005_bib1030","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1084\/jem.178.2.489","article-title":"The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas","volume":"178","author":"Brichard","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.ad.2016.05.005_bib1035","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1600-0560.1998.tb01720.x","article-title":"Tyrosinase immunoreactivity in formalin-fixed, paraffin-embedded primary and metastatic melanoma: frequency and distribution","volume":"25","author":"Hofbauer","year":"1998","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1040","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0344-0338(00)80072-2","article-title":"T311--an anti-tyrosinase monoclonal antibody for the detection of melanocytic lesions in paraffin embedded tissues","volume":"196","author":"Jungbluth","year":"2000","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.ad.2016.05.005_bib1045","doi-asserted-by":"crossref","first-page":"816","DOI":"10.5858\/2002-126-0816-TEIMMD","article-title":"Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors","volume":"126","author":"Boyle","year":"2002","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ad.2016.05.005_bib1050","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/oxfordjournals.jbchem.a022548","article-title":"Molecular cloning of cDNA encoding a novel microphthalmia-associated transcription factor isoform with a distinct amino-terminus","volume":"126","author":"Fuse","year":"1999","journal-title":"J Biochem"},{"key":"10.1016\/j.ad.2016.05.005_bib1055","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.molmed.2006.07.008","article-title":"MITF: master regulator of melanocyte development and melanoma oncogene","volume":"12","author":"Levy","year":"2006","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ad.2016.05.005_bib1060","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0092-8674(02)00762-6","article-title":"Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability","volume":"109","author":"McGill","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.ad.2016.05.005_bib1065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00000478-200102000-00007","article-title":"Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma","volume":"25","author":"Busam","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00000478-200102000-00008","article-title":"Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers","volume":"25","author":"Miettinen","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00000372-200106000-00004","article-title":"Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma","volume":"23","author":"Granter","year":"2001","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1080","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/cncy.21458","article-title":"Reliability of immunostaining using pan-melanoma cocktail, SOX10, and microphthalmia transcription factor in confirming a diagnosis of melanoma on fine-needle aspiration smears","volume":"122","author":"Clevenger","year":"2014","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/DAD.0b013e31825666c3","article-title":"MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations","volume":"35","author":"Nybakken","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1090","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/DAD.0b013e318291485c","article-title":"Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases","volume":"36","author":"Buonaccorsi","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1095","doi-asserted-by":"crossref","first-page":"37978","DOI":"10.1074\/jbc.M003816200","article-title":"Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2","volume":"275","author":"Lee","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ad.2016.05.005_bib1100","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1038\/sj.onc.1206442","article-title":"The importance of having your SOX on: role of SOX10 in the development of neural crest-derived melanocytes and glia","volume":"22","author":"Mollaaghababa","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ad.2016.05.005_bib1105","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/PAS.0000000000000398","article-title":"Sox10-a marker for not only schwannian and melanocytic neoplasms but also myoepithelial cell tumors of soft tissue: a systematic analysis of 5134 tumors","volume":"39","author":"Miettinen","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1110","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/PAI.0b013e318279bc0a","article-title":"SOX10 expression in malignant melanoma, carcinoma, and normal tissues","volume":"21","author":"Mohamed","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ad.2016.05.005_bib1115","doi-asserted-by":"crossref","first-page":"530","DOI":"10.5858\/arpa.2014-0077-OA","article-title":"A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas","volume":"139","author":"Tacha","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ad.2016.05.005_bib1120","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/DAD.0b013e31827a0b98","article-title":"SOX10 expression distinguishes desmoplastic melanoma from its histologic mimics","volume":"35","author":"Palla","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1125","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/jid.2014.454","article-title":"CD271 mediates stem cells to early progeny transition in human epidermis","volume":"135","author":"Truzzi","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib1130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/36.4.2831267","article-title":"Immunohistochemical analysis of nerve growth factor receptor expression in normal and malignant human tissues","volume":"36","author":"Chesa","year":"1988","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.ad.2016.05.005_bib1135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/DAD.0b013e318225b596","article-title":"P75 nerve growth factor receptor as a useful marker to distinguish spindle cell melanoma from other spindle cell neoplasms of sun-damaged skin","volume":"34","author":"Sigal","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1140","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1600-0560.2011.01718.x","article-title":"Diagnostic utility of low-affinity nerve growth factor receptor (P 75) immunostaining in atypical fibroxanthoma","volume":"38","author":"Bull","year":"2011","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1145","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/DAD.0b013e3181dfcb9f","article-title":"NGFR (p75) expression in cutaneous scars; further evidence for a potential pitfall in evaluation of reexcision scars of cutaneous neoplasms, in particular desmoplastic melanoma","volume":"33","author":"Otaibi","year":"2011","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1150","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1053\/hupa.2001.27602","article-title":"Low-affinity nerve growth factor receptor (p75) in dermatofibrosarcoma protuberans and other nonneural tumors: a study of 1,150 tumors and fetal and adult normal tissues","volume":"32","author":"Fanburg-Smith","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1155","first-page":"4904","article-title":"Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognizing separate cell surface antigenic determinants","volume":"45","author":"Krizan","year":"1985","journal-title":"Cancer Res"},{"key":"10.1016\/j.ad.2016.05.005_bib1160","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/09674845.2002.11783659","article-title":"Evaluation of melanocytic neoplasms: application of a pan-melanoma antibody cocktail","volume":"59","author":"Orchard","year":"2002","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.ad.2016.05.005_bib1165","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1083\/jcb.123.3.513","article-title":"The cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins","volume":"123","author":"Schluter","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ad.2016.05.005_bib1170","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0190-9622(97)80121-1","article-title":"Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions","volume":"37","author":"Rudolph","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib1175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/DAD.0b013e3181624054","article-title":"Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions","volume":"30","author":"Nasr","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1180","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00000372-200012000-00002","article-title":"A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions","volume":"22","author":"Li","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/1523-1747.ep12312431","article-title":"MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas","volume":"105","author":"Ramsay","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib1190","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1067\/mjd.2001.110067","article-title":"Correlation of Ki-67 expression in cutaneous primary melanoma with prognosis in a prospective study: different correlation according to thickness","volume":"44","author":"Moretti","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib1195","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/1471-2407-10-140","article-title":"Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma","volume":"10","author":"Ladstein","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ad.2016.05.005_bib1200","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/PAS.0000000000000224","article-title":"Suprabasal spread of melanocytes in dysplastic nevi and melanoma in situ: Ki-67-labeling rate of junctional melanocytes and suprabasal cells may be a helpful clue to the diagnosis","volume":"38","author":"Hall","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1205","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ad.2016.05.005_bib1210","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s004120050256","article-title":"Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation","volume":"106","author":"Hendzel","year":"1997","journal-title":"Chromosoma"},{"key":"10.1016\/j.ad.2016.05.005_bib1215","first-page":"695","article-title":"H3 phosphorylation: dual role in mitosis and interphase","volume":"87","author":"Perez-Cadahia","year":"2009","journal-title":"Biochem Cell Biol"},{"key":"10.1016\/j.ad.2016.05.005_bib1220","first-page":"35","article-title":"Emerging clinical applications of selected biomarkers in melanoma","volume":"8","author":"Tetzlaff","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib1225","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/modpathol.2013.59","article-title":"Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma","volume":"26","author":"Tetzlaff","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1230","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/modpathol.2012.188","article-title":"Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage I\/II melanoma","volume":"26","author":"Nielsen","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1235","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/DAD.0b013e3181cf7cc1","article-title":"Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma","volume":"32","author":"Casper","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1240","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/DAD.0b013e31823135a3","article-title":"pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas","volume":"34","author":"Schimming","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1245","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-0560.2011.01858.x","article-title":"Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma","volume":"39","author":"Ikenberg","year":"2012","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1250","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/modpathol.3880543","article-title":"Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas","volume":"15","author":"Kahn","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1255","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2559.2005.02098.x","article-title":"Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours","volume":"46","author":"Fukunaga","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.ad.2016.05.005_bib1260","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/archderm.144.4.462","article-title":"Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma","volume":"144","author":"Niakosari","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib1265","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-0560.2008.01242.x","article-title":"Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival","volume":"36","author":"Petersson","year":"2009","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1270","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1600-0560.2008.01166.x","article-title":"Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis","volume":"36","author":"Doeden","year":"2009","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1275","first-page":"1001","article-title":"Lymphovascular invasion: assessment and prognostic impact in melanoma and breast cancer","volume":"30","author":"Thompson","year":"2015","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1280","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaad.2009.04.026","article-title":"Lymphatic invasion detected by D2-40\/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma","volume":"61","author":"Petitt","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib1285","article-title":"Prognostic significance of lymphovascular invasion detected by double immunostaining for D2-40 and MITF1 in patients with cutaneous melanoma","author":"Feldmeyer","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1290","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ad.2016.05.005_bib1295","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1479-5876-10-85","article-title":"The role of BRAF V600 mutation in melanoma","volume":"10","author":"Ascierto","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/j.ad.2016.05.005_bib1300","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2217\/fon.14.252","article-title":"Vemurafenib for the treatment of BRAF mutant metastatic melanoma","volume":"11","author":"Martin-Liberal","year":"2015","journal-title":"Future Oncol"},{"key":"10.1016\/j.ad.2016.05.005_bib1305","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/PAS.0b013e31826485c0","article-title":"Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma","volume":"37","author":"Long","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1310","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00401-011-0841-z","article-title":"Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody","volume":"122","author":"Capper","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1315","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.humpath.2013.06.018","article-title":"Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas","volume":"44","author":"Routhier","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1320","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.humpath.2015.04.012","article-title":"Utility of BRAF V600E immunohistochemical expression pattern as a surrogate of BRAF mutation status in 154 patients with advanced melanoma","volume":"46","author":"Tetzlaff","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1325","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1038\/jid.2015.229","article-title":"Intra- and inter-tumoral homogeneity of BRAF(V600E) mutations in melanoma tumors","volume":"135","author":"Riveiro-Falkenbach","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib1330","doi-asserted-by":"crossref","first-page":"e29336","DOI":"10.1371\/journal.pone.0029336","article-title":"Intra- and inter-tumor heterogeneity of BRAF(V600E)mutations in primary and metastatic melanoma","volume":"7","author":"Yancovitz","year":"2012","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ad.2016.05.005_bib1335","doi-asserted-by":"crossref","DOI":"10.1111\/cup.12714","article-title":"Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas","author":"Ravishankar","year":"2016","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1340","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/PAI.0000000000000013","article-title":"BRAF mutations in metastatic malignant melanoma: comparison of molecular analysis and immunohistochemical expression","volume":"22","author":"Ehsani","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.ad.2016.05.005_bib1345","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1749-6632.1999.tb09414.x","article-title":"BAP1, a candidate tumor suppressor protein that interacts with BRCA1","volume":"886","author":"Jensen","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ad.2016.05.005_bib1350","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ad.2016.05.005_bib1355","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ad.2016.05.005_bib1360","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/PAT.0b013e32835d0efb","article-title":"Tumours associated with BAP1 mutations","volume":"45","author":"Murali","year":"2013","journal-title":"Pathology"},{"key":"10.1016\/j.ad.2016.05.005_bib1365","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jmedgenet-2011-100156","article-title":"Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers","volume":"48","author":"Abdel-Rahman","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.ad.2016.05.005_bib1370","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/ng.910","article-title":"Germline mutations in BAP1 predispose to melanocytic tumors","volume":"43","author":"Wiesner","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/j.ad.2016.05.005_bib1375","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/cup.12493","article-title":"Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome","volume":"42","author":"Marusic","year":"2015","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1380","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1097\/PAS.0b013e3182498be5","article-title":"A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression","volume":"36","author":"Wiesner","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1385","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.humpath.2014.10.015","article-title":"BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations","volume":"46","author":"Piris","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1390","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PAS.0000000000000187","article-title":"Clinical and pathologic findings of Spitz nevi and atypical Spitz tumors with ALK fusions","volume":"38","author":"Busam","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1395","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/PAS.0b013e318263648c","article-title":"Combined BRAF(V600E)-positive melanocytic lesions with large epithelioid cells lacking BAP1 expression and conventional nevomelanocytes","volume":"37","author":"Busam","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1400","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaad.2013.10.032","article-title":"Histopathologic clues for the diagnosis of Wiesner nevus","volume":"70","author":"Llamas-Velasco","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib1405","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/jid.2014.528","article-title":"BAP1 has a survival role in cutaneous melanoma","volume":"135","author":"Kumar","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib1410","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0165-4608(84)90024-4","article-title":"Cytogenetics of human malignant melanoma and premalignant lesions","volume":"11","author":"Balaban","year":"1984","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.ad.2016.05.005_bib1415","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0165-4608(88)90186-0","article-title":"Chromosome changes in metastatic human melanoma","volume":"30","author":"Limon","year":"1988","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.ad.2016.05.005_bib1420","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.jaad.2015.02.1140","article-title":"Practical application of new technologies for melanoma diagnosis: Part II. Molecular approaches","volume":"72","author":"March","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib1425","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1359641","article-title":"Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors","volume":"258","author":"Kallioniemi","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ad.2016.05.005_bib1430","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/(SICI)1098-2264(199908)25:4<410::AID-GCC17>3.0.CO;2-J","article-title":"Deletions below 10 megabasepairs are detected in comparative genomic hybridization by standard reference intervals","volume":"25","author":"Kirchhoff","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ad.2016.05.005_bib1435","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/gcc.10155","article-title":"DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones","volume":"36","author":"Fiegler","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ad.2016.05.005_bib1440","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/ng1307","article-title":"A tiling resolution DNA microarray with complete coverage of the human genome","volume":"36","author":"Ishkanian","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/j.ad.2016.05.005_bib1445","first-page":"2170","article-title":"Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization","volume":"58","author":"Bastian","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ad.2016.05.005_bib1450","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0002-9440(10)63536-5","article-title":"Classifying melanocytic tumors based on DNA copy number changes","volume":"163","author":"Bastian","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1455","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1529-8019.2005.00055.x","article-title":"Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool","volume":"19","author":"Bauer","year":"2006","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ad.2016.05.005_bib1460","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/cyto.1131","article-title":"Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization","volume":"46","author":"Balazs","year":"2001","journal-title":"Cytometry"},{"key":"10.1016\/j.ad.2016.05.005_bib1465","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/gcc.20785","article-title":"Somatic alterations in the melanoma genome: a high-resolution array-based comparative genomic hybridization study","volume":"49","author":"Gast","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ad.2016.05.005_bib1470","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1038\/sj.onc.1210252","article-title":"Genomic profiling of malignant melanoma using tiling-resolution array CGH","volume":"26","author":"Jonsson","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ad.2016.05.005_bib1475","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1158\/0008-5472.CAN-06-4152","article-title":"Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays","volume":"67","author":"Stark","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.ad.2016.05.005_bib1480","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1056\/NEJMoa050092","article-title":"Distinct sets of genetic alterations in melanoma","volume":"353","author":"Curtin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ad.2016.05.005_bib1485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cancergencyto.2004.06.004","article-title":"Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome","volume":"157","author":"Namiki","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.ad.2016.05.005_bib1490","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/gcc.22160","article-title":"Increased frequency of minimal homozygous deletions is associated with poor prognosis in primary malignant melanoma patients","volume":"53","author":"Boi","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.ad.2016.05.005_bib1495","doi-asserted-by":"crossref","first-page":"830","DOI":"10.5858\/2011-0048-RAIR.1","article-title":"Update on fluorescence in situ hybridization in melanoma: state of the art","volume":"135","author":"Gerami","year":"2011","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ad.2016.05.005_bib1500","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/PAS.0b013e3181a1ef36","article-title":"Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma","volume":"33","author":"Gerami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1505","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archdermatol.2009.386","article-title":"Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes","volume":"146","author":"Gerami","year":"2010","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2016.05.005_bib1510","first-page":"303","article-title":"Useful mass spectrometry programs freely available on the Internet","volume":"367","author":"Matthiesen","year":"2007","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ad.2016.05.005_bib1515","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/PAS.0b013e3181a92cbc","article-title":"Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization","volume":"33","author":"Pouryazdanparast","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1520","first-page":"335","article-title":"Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus-like melanoma","volume":"38","author":"Gammon","year":"2011","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1525","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0560.2010.01666.x","article-title":"Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi","volume":"38","author":"Gerami","year":"2011","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1530","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/PAS.0b013e3181ba6db6","article-title":"Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi","volume":"33","author":"Gerami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1535","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/modpathol.2009.72","article-title":"Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma","volume":"22","author":"Newman","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1540","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1600-0560.2009.01488.x","article-title":"Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization","volume":"37","author":"Busam","year":"2010","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1545","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/PAS.0b013e3181c805c4","article-title":"Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma","volume":"34","author":"Dalton","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1550","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/modpathol.2010.228","article-title":"Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases","volume":"24","author":"Vergier","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1555","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/modpathol.2009.177","article-title":"Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up","volume":"23","author":"Gaiser","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1560","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.5858\/arpa.2011-0673-OA","article-title":"Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions","volume":"136","author":"Zembowicz","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ad.2016.05.005_bib1565","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/PAS.0b013e31829d20f5","article-title":"Ambiguous melanocytic tumors in a tertiary referral center: the contribution of fluorescence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analyses","volume":"37","author":"Tetzlaff","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1570","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/1066896912445923","article-title":"Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status","volume":"20","author":"Fang","year":"2012","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1575","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2559.2011.04087.x","article-title":"Presence of cytogenetic abnormalities in Spitz naevi: a diagnostic challenge for fluorescence in-situ hybridization analysis","volume":"60","author":"Martin","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.ad.2016.05.005_bib1580","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/DAD.0b013e3181b72d6f","article-title":"Polyploidy in spitz nevi: a not uncommon karyotypic abnormality identifiable by fluorescence in situ hybridization","volume":"32","author":"Isaac","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1585","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/PAS.0b013e31824b1efd","article-title":"A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms","volume":"36","author":"Gerami","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1590","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31822d5ff8","article-title":"Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe","volume":"36","author":"Gammon","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1595","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jprot.2014.03.021","article-title":"MALDI imaging mass spectrometry: spatial molecular analysis to enable a new age of discovery","volume":"107","author":"Gessel","year":"2014","journal-title":"J Proteomics"},{"key":"10.1016\/j.ad.2016.05.005_bib1600","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00216-008-1972-5","article-title":"In situ molecular imaging of proteins in tissues using mass spectrometry","volume":"391","author":"Hardesty","year":"2008","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.ad.2016.05.005_bib1605","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/DAD.0b013e31823df1e2","article-title":"Imaging mass spectrometry \u2013 a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas","volume":"34","author":"Lazova","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.ad.2016.05.005_bib1610","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/cup.12523","article-title":"Congenital nevi versus metastatic melanoma in a newborn to a mother with malignant melanoma - diagnosis supported by sex chromosome analysis and Imaging Mass Spectrometry","volume":"42","author":"Alomari","year":"2015","journal-title":"J Cutan Pathol"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731016301545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731016301545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:05:33Z","timestamp":1757552733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731016301545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":161,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0001731016301545"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2016.05.005","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2016.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}